Header cover image

Italian (Borsa Italiana) Healthcare Sector Analysis

UpdatedMar 17, 2025
DataAggregated Company Financials
Companies16
  • 7D-3.4%
  • 3M-5.3%
  • 1Y-11.2%
  • YTD-6.1%

The Healthcare industry is down 3.4% over the last week with Amplifon the worst performer, down 6.2%. However, the industry is down 11% over the past year. As for the next few years, earnings are expected to grow by 11% per annum.

Sector Valuation and Performance

Has the Italian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 18 Mar 2025€22.9b€19.6b€796.0m21.2x28.8x1.2x
Thu, 13 Feb 2025€26.0b€20.0b€828.0m23.6x31.4x1.3x
Sat, 11 Jan 2025€24.9b€8.0b€834.7m22.1x29.8x3.1x
Mon, 09 Dec 2024€24.6b€19.0b€1.4b19.2x17.2x1.3x
Wed, 06 Nov 2024€24.7b€18.9b€1.4b16.1x18x1.3x
Fri, 04 Oct 2024€24.4b€18.9b€1.4b17.2x17.7x1.3x
Sun, 01 Sep 2024€26.1b€18.9b€1.4b15.4x18.8x1.4x
Tue, 30 Jul 2024€26.0b€18.8b€1.4b17.1x18.8x1.4x
Thu, 27 Jun 2024€25.8b€18.8b€1.4b16x18.6x1.4x
Sat, 25 May 2024€26.0b€18.8b€1.4b17.2x18.8x1.4x
Mon, 22 Apr 2024€25.3b€18.7b€1.4b19.3x18.4x1.4x
Wed, 20 Mar 2024€25.7b€18.6b€1.4b20.4x18.4x1.4x
Fri, 16 Feb 2024€25.0b€18.6b€1.4b18.7x18x1.3x
Sun, 14 Jan 2024€25.3b€18.6b€1.4b18.1x18.2x1.4x
Tue, 12 Dec 2023€23.6b€18.6b€1.4b18.3x16.9x1.3x
Thu, 09 Nov 2023€22.7b€18.6b€1.4b17x16.2x1.2x
Sat, 07 Oct 2023€22.7b€18.6b€1.4b16.5x15.7x1.2x
Mon, 04 Sep 2023€23.8b€17.3b€1.1b16x20.9x1.4x
Wed, 02 Aug 2023€24.0b€7.8b€857.4m15.3x28x3.1x
Fri, 30 Jun 2023€23.9b€7.7b€822.5m17.5x29.1x3.1x
Sun, 28 May 2023€24.2b€7.7b€822.5m22.6x29.4x3.1x
Tue, 25 Apr 2023€24.0b€7.6b€826.9m21.2x29x3.2x
Thu, 23 Mar 2023€22.8b€7.6b€868.1m19x26.3x3x
Sat, 18 Feb 2023€23.9b€7.4b€886.1m24.7x27x3.2x
Mon, 16 Jan 2023€24.0b€7.4b€886.1m23.9x27.1x3.2x
Wed, 14 Dec 2022€25.0b€7.4b€886.1m22.7x28.2x3.4x
Fri, 11 Nov 2022€24.8b€7.3b€895.7m21.3x27.7x3.4x
Sun, 09 Oct 2022€21.8b€7.3b€908.8m20.1x24x3x
Tue, 06 Sep 2022€23.9b€7.2b€886.8m22x26.9x3.3x
Thu, 04 Aug 2022€26.2b€7.1b€900.9m23.1x29.1x3.7x
Sat, 02 Jul 2022€25.2b€6.9b€957.4m21.2x26.3x3.7x
Mon, 30 May 2022€26.0b€7.0b€966.7m21.8x26.9x3.7x
Wed, 27 Apr 2022€27.7b€6.8b€952.4m23.3x29.1x4.1x
Fri, 25 Mar 2022€28.2b€6.7b€951.9m22.9x29.6x4.2x
Price to Earnings Ratio

29.6x


Total Market Cap: €28.2bTotal Earnings: €951.9mTotal Revenue: €6.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Italian Healthcare Sector Price to Earnings3Y Average 23.5x202320242025
Current Industry PE
  • Investors are optimistic on the Italian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 28.8x which is higher than its 3-year average PE of 23.5x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.2% per year over the last three years.
  • Meanwhile revenues for these companies have grown 40% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Italian Healthcare sector?

IT Market1.36%
Healthcare-3.40%
Biotech1.97%
Life Sciences-1.21%
Pharma-1.59%
Healthtech-3.80%
Healthcare Services-3.80%
Medical Equipment-6.88%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 36.3x.
    • Analysts are expecting annual earnings growth of 18.5%, which is higher than its past year's earnings decline of 1.0% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 43% over the next 5 years.
  • However this is lower than its past earnings growth rate of 280% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 75% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PHIL Philogen€18.952.4%
+€18.1m
6.5%PS194.8x
GHC Garofalo Health Care€4.970.4%
+€1.8m
3.8%PE20.3x
HI Health Italia€119.007.7%
+€1.6m
-4.8%PE13.2x
IVN iVision Tech€2.349.3%
+€1.6m
196.2%PS0.002x
UBM Ulisse Biomed€0.791.3%
+€244.8k
-44.5%PS45.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AMP

€19.95

Amplifon

7D

-6.3%

1Y

-37.1%

GHC

€4.97

Garofalo Health Care

7D

0.4%

1Y

3.8%

ELN

€8.93

EL.En

7D

-21.1%

1Y

-12.6%

HI

€119.00

Health Italia

7D

7.7%

1Y

-4.8%

IVN

€2.34

iVision Tech

7D

9.3%

1Y

196.2%

IMD

€1.38

I.M.D. International Medical Devices

7D

-1.4%

1Y

-5.2%

GPI

€8.30

GPI

7D

-4.4%

1Y

-30.9%

PRE

€0.49

Predict

7D

-3.0%

1Y

n/a

PHIL

€18.95

Philogen

7D

2.4%

1Y

6.5%

ARBS

€2.10

Arterra Bioscience

7D

1.0%

1Y

0%

UBM

€0.79

Ulisse Biomed

7D

1.3%

1Y

-44.5%